Clinical Trial Update: Efficacy and Safety Study of Pitavastatin and Atorvastatin in High Risk Hypercholesterolemic Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the efficacy and safety of pitavastatin and atorvastatin in high-risk hyperlipidemic patients; the status of the study is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia
• Hyperlipidemia

Drugs mentioned

• Pitavastatin (Pitavastatin)
• atorvastatin (atorvastatin)

Snippet

Sponsor: Tai Tien Pharmaceuticals Co., Ltd. | Conditions: Hyperlipidemia | Phase 3 | Status: UNKNOWN